| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |